JANE STREET GROUP, LLC - NYMOX PHARMACEUTICAL CORP ownership

NYMOX PHARMACEUTICAL CORP's ticker is NYMX and the CUSIP is P73398102. A total of 30 filers reported holding NYMOX PHARMACEUTICAL CORP in Q4 2016. The put-call ratio across all filers is 3.40 and the average weighting 0.0%.

Quarter-by-quarter ownership
JANE STREET GROUP, LLC ownership history of NYMOX PHARMACEUTICAL CORP
ValueSharesWeighting
Q4 2022$8,123
-75.4%
25,126
-2.1%
0.00%
Q4 2021$33,000
-50.7%
25,658
-39.3%
0.00%
Q2 2021$67,000
-36.8%
42,251
-1.9%
0.00%
Q3 2020$106,000
-64.2%
43,052
-48.3%
0.00%
Q2 2020$296,000
+557.8%
83,321
+337.1%
0.00%
Q1 2020$45,000
+2.3%
19,063
+40.2%
0.00%
Q3 2016$44,00013,6000.00%
Other shareholders
NYMOX PHARMACEUTICAL CORP shareholders Q4 2016
NameSharesValueWeighting ↓
Corrigan Financial, Inc. 302,252$102,7660.03%
Virtu Financial LLC 13,324$50.00%
Bleakley Financial Group, LLC 80,000$27,2000.00%
Beaird Harris Wealth Management, LLC 24,400$8,2960.00%
One Day In July LLC 10,000$3,4000.00%
Cubic Asset Management, LLC 10,000$3,4000.00%
WMS Partners, LLC 18,000$6,1200.00%
Simplicity Solutions, LLC 80,000$27,2000.00%
WELLS FARGO & COMPANY/MN 3,296$1,1210.00%
CONCOURSE FINANCIAL GROUP SECURITIES, INC. 0$00.00%
View complete list of NYMOX PHARMACEUTICAL CORP shareholders